Literature DB >> 8093812

V-erbA requires auxiliary proteins for dominant negative activity.

T Hermann1, B Hoffmann, F J Piedrafita, X K Zhang, M Pfahl.   

Abstract

The avian v-erbA protein is an important example of a dominant negative oncogene. It has been identified as a highly mutated form of its cellular homolog, the thyroid hormone receptor alpha (TR-alpha), and its biological activity has been correlated with its repressor function on certain receptor-regulated genes. Although v-erbA has lost the hormone responsiveness of its cellular homolog, it has retained DNA-binding activity, and it has been implied that this function is required for repression and transformation. Here we demonstrate that v-erbA forms heterodimers with the retinoid X receptor (RXR-alpha). Only heteromeric v-erbA-RXR-alpha complexes show DNA-binding strong enough to account for its potent repressor function. In addition, v-erbA-RXR-alpha heterodimers specifically bind natural thyroid hormone-responsive elements (TREs) but not retinoic acid-responsive elements (RAREs). Repression of TRE-controlled gene expression by v-erbA requires the presence of RXR-alpha with the natural TREs tested. In contrast, natural RAREs investigated here do not bind the v-erbA-RXR-alpha heterodimer and also are not significantly repressed by v-erbA. Carboxy-terminal mutations that abolish v-erbA-RXR-alpha heterodimer formation also abolish v-erbA repressor activity. These data suggest that interaction of v-erbA with RXRs or similar auxiliary receptors is essential for the dominant negative activity of the v-erbA oncogene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8093812

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.

Authors:  A Rascle; N Ferrand; O Gandrillon; J Samarut
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

2.  Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.

Authors:  K Damm; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

3.  A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily.

Authors:  R Apfel; D Benbrook; E Lernhardt; M A Ortiz; G Salbert; M Pfahl
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

4.  The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.

Authors:  H W Chen; M L Privalsky
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

5.  Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor.

Authors:  X K Zhang; G Salbert; M O Lee; M Pfahl
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

6.  Thyroid hormone receptor can modulate retinoic acid-mediated axis formation in frog embryogenesis.

Authors:  D E Banker; R N Eisenman
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

7.  Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.

Authors:  P Ciana; G G Braliou; F G Demay; M von Lindern; D Barettino; H Beug; H G Stunnenberg
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

8.  Formation of retinoid X receptor homodimers leads to repression of T3 response: hormonal cross talk by ligand-induced squelching.

Authors:  J M Lehmann; X K Zhang; G Graupner; M O Lee; T Hermann; B Hoffmann; M Pfahl
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

9.  A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene.

Authors:  M O Lee; Y Liu; X K Zhang
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

10.  Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA.

Authors:  C Barlow; B Meister; M Lardelli; U Lendahl; B Vennström
Journal:  EMBO J       Date:  1994-09-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.